This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated TWIST1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-TWIST1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~21 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | — | |
| Caveat | — | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A00980 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Jurkat (40ug), RAW264.7 (40ug) (catalog A00980) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A00980; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
TWIST1 is predicted at 21 kDa; dimerization could affect migration, but no shifted band or empirical band size is established.
| Band near 21 kDa | consistent with predicted full-length TWIST1; confirm identity with antibody controls |
| Band near 42 kDa | could reflect a TWIST1 homodimer if it survives sample preparation |
| Higher band of uncertain size | could reflect a surviving complex with another bHLH protein; identity requires confirmation |
| Weak band in a cytosolic fraction | consistent with TWIST1's nuclear location |
| Predicted molecular mass | places the full-length monomer near 21 kDa |
| 202-amino-acid sequence | defines the full-length protein underlying the predicted mass |
| TWIST1 homodimerization | could produce a band near twice the monomer size if the dimer survives sample preparation |
| Heterodimerization with E proteins such as TCF3 | could produce a higher band if the complex survives; its apparent size is not supplied |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | nuclear TWIST1 may be poorly recovered | check nuclear extraction and a nuclear fraction control |
| Band higher than expected | a TWIST1 dimer may survive sample preparation | compare denaturing conditions and verify TWIST1 identity |
| Band lower than expected | band identity is uncertain; no cleavage feature is listed | check antibody specificity and compare an independent TWIST1 antibody |
| Multiple bands | monomer and surviving dimers are possible, but identities are unproven | compare denaturing conditions and verify each band |
| Weak or no signal | nuclear TWIST1 may be diluted in whole-cell lysate | enrich the nuclear fraction and check extraction recovery |
| Fragments below expected size | degradation or nonspecific binding is possible | check sample integrity and validate with an independent antibody |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for TWIST1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Both antibodies list human and mouse reactivity and have WB images. A00980’s caption reports Jurkat and RAW264.7 lysates at 1:500, with 40 µg per lane. M00980’s lists NIH/3T3 and five other cell lysates. No publication evidence was supplied.
Which to pick: Choose A00980 if its reported Jurkat or RAW264.7 samples and 1:500 dilution match your setup. Choose M00980 for a monoclonal antibody with WB examples using NIH/3T3, Jurkat, HeLa, A549, Raji, and OCM1 lysates.